Prot #RIN-PF-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date4/28/224/28/25

Funding

  • United Therapeutics Corporation ((OE) Prot #RIN-PF-301)